Tablet Coatings Market - Major Revenue Growth is Expected in the Near Future

Posted June 8, 2022 by mmvaidya

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Major Growth Influencing Factors:

Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. The growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market. Moreover, the shifting focus of pharmaceutical manufacturing to emerging markets along with the increasing outsourcing of operations to these countries present significant opportunities for market growth.

Additionally, the rising focus on technological advancements in niche market areas also offers significant growth opportunities for players operating in this space. However, the increasing regulatory stringency regarding the approval of drugs and excipients, the high cost associated with the microencapsulation process are expected to restrain the growth of this market during the forecast period.

Expected Revenue Gains:

The tablet coatings market is projected to reach USD 969 million by 2025 from USD 739 million in 2020, at a CAGR of 5.6% during the forecast period.

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by polymer type, functionality, type, end user, and region).

Download PDF Brochure@

Data Triangulation:

After arriving at the market size, the total tablet coatings market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

COVID-19 Impact on Global Tablet Coatings Market:

COVID-19 has given momentum to the pharmaceutical and nutraceutical market. Currently, there is a high demand for pharmaceutical products to treat COVID-19. This is expected to boost the demand for products such as tablet coating excipients. The clinical trial pipeline for COVID-19 includes a list of 155 molecules in various stages of development. As the maximum number of molecules are repurposed drugs that are already approved for other infections and inflammatory diseases, higher stages of development (namely phase 2 trials) hold the largest share of the drug development pipeline. Moreover, compassionate use allows for the use of an unlicensed drug (licenses can take years or decades) when no other options are available for treating high-risk patients.

On April 6, 2020, RedHill Biopharma announced that it had received authorization from the Italian National Institute for Infectious Diseases and the Central Italian Ethics Committee (EC) for an expanded access program (EAP), allowing the immediate and compassionate use of its investigational drug, opaganib (Yeliva), in Italy for patients with confirmed COVID-19 infections with life-threatening clinical manifestations. Considering such developments, it is expected that the production and use of unlicensed drugs are expected to increase in the coming years. This in turn is expected to drive the demand for tablet coatings.

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Europe is expected to account for the largest share of the tablet coatings market in 2019

In 2019, Europe accounted for the largest share of the tablet coatings market, followed by North America, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be characterized by the presence of a number of pharmaceutical giants with large production capacities leading to a high consumption of excipients. The growing emphasis on superior pharmaceutical products, generics, and biosimilars has also led to the increase in the demand for novel excipients, which, in turn, is expected to drive the market growth in this region in the coming years.

Request Sample Pages@

Key Market Players:

The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).

Recent Developments:

# In 2020, Colorcon launched the Acryl-EZE II film coating line which extends the pH range covered by its enteric coatings.

# In 2020, Evonik launched the EUDRATEC Fasteric releases, an advanced oral drug delivery technology that provides enteric protection followed by rapid, homogeneous release for effective targeting of the upper small intestine.

# In 2019, Ashland announced the launch of Aquarius Nutra TF, which provides titanium oxide-based coating to tablets in the European market.

# In 2019, Kerry Group opened its new USD 22 million (EUR 20 million) state-of-the-art facility in Bangalore, India to serve the Taste & Nutrition business division’s global and regional customers in the South West Asia region.

# In 2017, BASF Group opened the Innovation Campus Asia Pacific in India, marking the largest R&D investment in South Asia. The company invested USD 61.6 million (EUR 50 million) in this center to increase its global and regional research activities.

Find Out Detailed Information@
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Industry , Medical , News
Tags tablet coatings , tablet coatings market
Last Updated June 8, 2022